BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 99 filers reported holding BICYCLE THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is 2.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67,259 | +13.6% | 3,348 | +44.3% | 0.00% | – |
| Q2 2023 | $59,204 | +162.6% | 2,320 | +118.9% | 0.00% | – |
| Q1 2023 | $22,546 | -40.7% | 1,060 | -19.1% | 0.00% | – |
| Q4 2022 | $38,000 | +15.2% | 1,310 | -7.1% | 0.00% | – |
| Q3 2022 | $33,000 | +106.2% | 1,410 | +48.4% | 0.00% | – |
| Q2 2022 | $16,000 | -90.9% | 950 | -76.5% | 0.00% | – |
| Q1 2022 | $176,000 | -33.3% | 4,039 | -6.8% | 0.00% | – |
| Q4 2021 | $264,000 | +25.7% | 4,334 | -14.4% | 0.00% | – |
| Q3 2021 | $210,000 | -62.0% | 5,064 | -72.2% | 0.00% | -100.0% |
| Q2 2021 | $552,000 | +18.2% | 18,196 | +16.4% | 0.00% | 0.0% |
| Q1 2021 | $467,000 | +17.6% | 15,627 | -29.3% | 0.00% | 0.0% |
| Q4 2020 | $397,000 | -20.1% | 22,112 | -15.3% | 0.00% | 0.0% |
| Q3 2020 | $497,000 | -7.4% | 26,100 | -23.5% | 0.00% | -50.0% |
| Q2 2020 | $537,000 | +53600.0% | 34,100 | +34000.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 917,218 | $40,248,000 | 48.61% |
| GREAT POINT PARTNERS LLC | 550,592 | $24,160,000 | 5.84% |
| Logos Global Management LP | 950,000 | $41,686,000 | 5.40% |
| Deep Track Capital, LP | 1,855,993 | $81,441,000 | 5.22% |
| First Light Asset Management, LLC | 890,174 | $39,061,000 | 3.44% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,154,126 | $50,643,000 | 3.00% |
| Ikarian Capital, LLC | 478,784 | $21,009,000 | 2.76% |
| Opaleye Management Inc. | 175,000 | $7,679,000 | 2.38% |
| Frazier Life Sciences Management, L.P. | 603,521 | $26,483,000 | 2.26% |
| Altium Capital Management LP | 120,000 | $5,266,000 | 1.76% |